Probiotics use to treat irritable bowel syndrome

Bibliography

• Sainsbury A, Ford AC. Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents. Ther Adv Gastroenterol 2011;4:115-27
   PubMedGoogle Scholar
• Chey WD, Maneerattaporn M, Saad R. Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome. Gut Liver 2011;5:253-66
   PubMed Web of Science ®Google Scholar
• Wu JC. Complementary and alternative medicine modalities for the treatment of irritable bowel syndrome: facts or myths? Gastroenterol Hepatol (N Y) 2010;6:705-11
   PubMedGoogle Scholar
• Bixquert Jimenez M. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? Rev Esp Enferm Dig 2009;101:553-64
   PubMed Web of Science ®Google Scholar
• Khan S, Chang L. Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol 2010;7:565-81
   PubMed Web of Science ®Google Scholar
• Lee BJ, Bak YT. Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil 2011;17:252-66
   PubMed Web of Science ®Google Scholar
• Andrews EB, Eaton SC, Hollis KA, Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther 2005;22:935-42
   PubMed Web of Science ®Google Scholar
• Hungin AP, Chang L, Locke GR, Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005;21:1365-75
   PubMed Web of Science ®Google Scholar
• Saito YA, Schoenfeld P, Locke GR III. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002;97:1910-15
   PubMed Web of Science ®Google Scholar
• Chang L, Toner BB, Fukudo S, Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 2006;130:1435-46
   PubMed Web of Science ®Google Scholar
• Gilkin RJ Jr. The spectrum of irritable bowel syndrome: a clinical review. Clin Ther 2005;27:1696-709
   PubMed Web of Science ®Google Scholar
• Karantanos T, Markoutsaki T, Gazouli M, Current insights in to the pathophysiology of Irritable Bowel Syndrome. Gut Pathog 2010;2:3
   PubMed Web of Science ®Google Scholar
• Parkes GC, Sanderson JD, Whelan K. Treating irritable bowel syndrome with probiotics: the evidence. Proc Nutr Soc 2010;69:187-94
   PubMed Web of Science ®Google Scholar
• Madden JA, Hunter JO. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr 2002;88:S67-72
   Web of Science ®Google Scholar
• Madden JAJ. The intestinal microbiota and probiotics in irritable bowel syndrome. Scand J Nutr 2004;48:32-6
   Google Scholar
• Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastroenterol 2009;5:1548-53
   Google Scholar
• Darvish-Damavandi M, Nikfar S, Abdollahi M. A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome. World J Gastroenterol 2010;16:547-53
   PubMed Web of Science ®Google Scholar
• Rahimi R, Nikfar S, Abdollahi M. Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: a meta-analysis of randomized controlled trials. Arch Med Sci 2008;4:71-6
   Web of Science ®Google Scholar
• Rahimi R, Abdollahi M. Herbal medicines for the management of irritable bowel syndrome: a comprehensive review. World J Gastroenterol 2012;18:589-600
   PubMed Web of Science ®Google Scholar
• Trinkley KE, Nahata MC. Treatment of irritable bowel syndrome. J Clin Pharm Ther 2011;36:275-82
   PubMed Web of Science ®Google Scholar
• Salari P, Abdollahi M. Phosphodiesterase inhibitors in inflammatory bowel disease. Expert Opin Investig Drugs 2012;21:261-4
   PubMed Web of Science ®Google Scholar
• Mozaffari S, Abdollahi M. Melatonin, a promising supplement in inflammatory bowel disease: a comprehensive review of evidences. Curr Pharm Des 2011;17:4372-8
   PubMed Web of Science ®Google Scholar
• Nikfar S, Rahimi R, Rahimi F, Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum 2008;51:1775-80
   PubMed Web of Science ®Google Scholar
• Upadhyay N, Moudgal V. Probiotics: a review. JCOM 2012;19:76-84
   Google Scholar
• Quigley EM. The efficacy of probiotics in IBS. J Clin Gastroenterol 2008;42:S85-90
   PubMed Web of Science ®Google Scholar
• Camilleri M. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. J Clin Gastroenterol 2008;42:S123-5
   PubMed Web of Science ®Google Scholar
• Parwal M, Pareek R. Probiotic: a treatment new approach. Asian J Biochem Pharm Res 2011;3:448-54
   Google Scholar
• Nikfar S, Darvish-Damavandi M, Abdollahi M. A review and meta-analysis of the efficacy of antibiotics and probiotics in management of pouchitis. Int J Pharmacol 2010;6:826-35
   Google Scholar
• Spiller R. Review article: probiotics and prebiotics in irritable bowel syndrome. Aliment Pharmacol Ther 2008;28:385-96
   PubMed Web of Science ®Google Scholar
• Aragon G, Graham DB, Borum M, Doman DB. Probiotic therapy for irritable bowel syndrome. Gastroenterol Hepatol (N Y) 2010;6:39-44
   PubMedGoogle Scholar
• Dai C, Guandalini S, Zhao DH, Jiang M. Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function. Mol Cell Biochem 2012;362(1-2):43-53
   PubMed Web of Science ®Google Scholar
• Ringel Y, Ringel-Kulka T. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome. J Clin Gastroenterol 2011;45:S145-8
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Ford AC, Talley NJ, The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010;59:325-32
   PubMed Web of Science ®Google Scholar
• Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 2009;104:1033-49
   PubMed Web of Science ®Google Scholar
• Hoveyda N, Heneghan C, Mahtani KR, A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 2009;9:15
   PubMed Web of Science ®Google Scholar
• Barbara G, Stanghellini V, Cremon C, Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. J Clin Gastroenterol 2008;42:S214-17
   PubMed Web of Science ®Google Scholar
• McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008;14:2650-61
   PubMed Web of Science ®Google Scholar
• Nobaek S, Johansson ML, Molin G, Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000;95:1231-8
   PubMed Web of Science ®Google Scholar
• Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001;13:1143-7
   PubMed Web of Science ®Google Scholar
• Sen S, Mullan MM, Parker TJ, Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002;47:2615-20
   PubMed Web of Science ®Google Scholar
• Simren M, Syrous A, Lindh A, Effects of Lactobacillus plantarum 299V on symptoms and rectal sensitivity in patients with irritable bowel syndrome (IBS)d a randomized double blind controlled trial. Gastroenterology 2006;130:A600
   PubMed Web of Science ®Google Scholar
• Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 2004;38:S104-6
   PubMed Web of Science ®Google Scholar
• Kim HJ, Camilleri M, McKinzie S, A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:895-904
   PubMed Web of Science ®Google Scholar
• Kim HJ, Vazquez Roque MI, Camilleri M, A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005;17:687-96
   PubMed Web of Science ®Google Scholar
• Guandalini S, Magazzu` G, Chiaro A, VSL#3 improves symptoms in children with irritable bowel syndrome: amulticenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr 2010;51:24-30
   PubMed Web of Science ®Google Scholar
• O'Sullivan MA, O'Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 2000;32:294-301
   PubMedGoogle Scholar
• Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 2005;147:197-201
   PubMed Web of Science ®Google Scholar
• Gawro nska A, Dziechciarz P, Horvath A, Szajewska H. A random-ized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther 2007;25:177-84
   PubMed Web of Science ®Google Scholar
• Francavilla R, Miniello V, Magista ` AM, Randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics 2010;126:e1445-52
   PubMed Web of Science ®Google Scholar
• Niv E, Naftali T, Hallak R, Vaisman N. The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome - a double blind, placebo-controlled, randomized study. Clin Nutr 2005;24:925-31
   PubMed Web of Science ®Google Scholar
• O'Mahony L, McCarthy J, Kelly P, Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-51
   PubMed Web of Science ®Google Scholar
• Whorwell PJ, Altringer L, Morel J, Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006;101:1581-90
   PubMed Web of Science ®Google Scholar
• Sinn DH, Song JH, Kim HJ, Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci 2008;53:2714-18
   PubMed Web of Science ®Google Scholar
• Choi CH, Jo SY, Park HJ, A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. J Clin Gastroenterol 2011;45:679-83
   PubMed Web of Science ®Google Scholar
• Dolin BJ. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Find Exp Clin Pharmacol 2009;31:655-9
   PubMed Web of Science ®Google Scholar
• Kajander K, Hatakka K, Poussa T, A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 2005;22:387-94
   PubMed Web of Science ®Google Scholar
• Kim YG, Moon JT, Lee KM, The effects of probiotics on symptoms of irritable bowel syndrome. Korean J Gastroenterol 2006;47:413-19
   PubMedGoogle Scholar
• Long ZR, Yu CH, Yang Y, Clinical observation on acupuncture combined with microorganism pharmaceutical preparations for treatment of irritable bowel syndrome of constipation type. Zhongguo Zhenjiu 2006;26:403-5
   PubMedGoogle Scholar
• Guyonnet D, Chassany O, Ducrotte P, Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007;26:475-86
   PubMed Web of Science ®Google Scholar
• Kajander K, Myllyluoma E, Rajilic-Stojanovic M, Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 2008;27:48-57
   PubMed Web of Science ®Google Scholar
• Agrawal A, Houghton LA, Morris J, Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2008;29:104-14
   PubMed Web of Science ®Google Scholar
• Enck P, Zimmermann K, Menke G, A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome: a randomized controlled trial with primary care physicians. Neurogastroenterol Motil 2008;20:1103-9
   PubMed Web of Science ®Google Scholar
• Williams EA, Stimpson J, Wang D, Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment Pharmacol Ther 2009;29:97-103
   PubMed Web of Science ®Google Scholar
• Hong KS, Kang HW, Im JP, Effect of probiotics on symptoms in Korean adults with irritable bowel syndrome. Gut Liver 2009;3:101-7
   PubMed Web of Science ®Google Scholar
• Ringel-Kulka T, Palsson OS, Maier D, Probiotic bacteria: probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders-a double-blind study. J Clin Gastroenterol 2011;45:518-25
   PubMed Web of Science ®Google Scholar
• Whorwell PJ. Do probiotics improve symptoms in patients with irritable bowel syndrome? Ther Adv Gastroenterol 2009;2:37-44
   PubMedGoogle Scholar
• Tsuchiya J, Barreto R, Okura R, Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome. Chin J Dig Dis 2004;5:169-74
   PubMedGoogle Scholar
• Simren M, Lindh A, Samuelsson L, Effect of yoghurt containing three probiotic bacteria in patients with irritable bowel syndrome (IBS) – a randomized, double-blind, controlled trial. Gastroenterology 2007;132:A210
   Web of Science ®Google Scholar
• Drouault-Holowacz S, Bieuvelet S, Burckel A, A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2008;32:147-52
   PubMedGoogle Scholar
• Andriulli A, Neri M, Loguercio C, Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study. J Clin Gastroenterol 2008;42:S218-23
   PubMed Web of Science ®Google Scholar
• Enck P, Zimmermann K, Menke G, Klosterhalfen S. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E. coli preparation (DSM17252) compared to placebo. Z Gastroenterol 2009;47:209-14
   PubMed Web of Science ®Google Scholar
• Simren M, Ohman L, Olsson J, Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome: a randomized, doubleblind, controlled study. Aliment Pharmacol Ther 2010;31:218-27
   PubMed Web of Science ®Google Scholar